Research demonstrates identification of terminal alkyne natural products using chemical isotope labeling and MALDI-TOF MS, suggesting enhanced detection methods for scarce compounds.
Terminal alkyne-containing natural products (TANPs) are pharmacologically valuable but remain underexplored due to their low abundance, instability, and inefficient isolation methodologies. Herein, we employed a structure-guided screening and isolation strategy integrating chemical isotope labeling (CIL) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for TANPs discovery. Parallel plant extracts were labeled via copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction using isotope labeling reagents ABI/d5-ABI, followed by MALDI-TOF MS analysis. This process generated stable labeled products with enhanced detection sensitivity and two distinctive features as screening criteria: (i) isotope peak pairs (Δm/z = 5.0314 Da) and (ii) N2 neutral loss (28.0056 Da), enabling rapid TANPs identification. Comparative chromatographic analysis of labeled/unlabeled samples allowed for oriented TANPs isolation. Guided by this method, five TANPs were successfully recognized, isolated, and identified from Spilanthes callimorpha for the first time, including a novel glycoside-containing compound. This CIL-MALDI-TOF MS method provides an efficient alternative for the discovery of TANPs in complex extracts.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: